title: B-type natriuretic peptide therapy in total artificial heart implantation: renal effects with early initiation.
authors.affiliation: Heart and Vascular Center Duisburg, Department for the Surgical Therapy of End-stage, Heart Failure and Mechanical Circulatory Support, Duisburg, Germany.
authors.forename: Sotirios
authors.initials: S
authors.lastname: Spiliopoulos
authors.affiliation: Heart and Vascular Center Duisburg, Department for the Surgical Therapy of End-stage, Heart Failure and Mechanical Circulatory Support, Duisburg, Germany.
authors.forename: Dilek
authors.initials: D
authors.lastname: Guersoy
authors.affiliation: Heart and Vascular Center Duisburg, Department for the Surgical Therapy of End-stage, Heart Failure and Mechanical Circulatory Support, Duisburg, Germany.
authors.forename: Reiner
authors.initials: R
authors.lastname: Koerfer
authors.affiliation: Heart and Vascular Center Duisburg, Department for the Surgical Therapy of End-stage, Heart Failure and Mechanical Circulatory Support, Duisburg, Germany.
authors.forename: Gero
authors.initials: G
authors.lastname: Tenderich
mesh_terms: D000328:Adult; D000368:Aged; D015331:Cohort Studies; D004334:Drug Administration Schedule; D005260:Female; D006333:Heart Failure / Q000628:therapy*; D006354:Heart, Artificial; D006801:Humans; D008297:Male; D008875:Middle Aged; D045283:Natriuretic Agents / Q000008:administration & dosage*; D020097:Natriuretic Peptide, Brain / Q000008:administration & dosage*; D051437:Renal Insufficiency / Q000517:prevention & control*
chemical_list: D045283:Natriuretic Agents; D020097:Natriuretic Peptide, Brain